Captor Therapeutics Discloses Molecular Targets of

CT-01 targets 3 well suited proteins including NEK7 with poor prognosis in key liver cancerStrong preclinical data generated with CT-02 against NEK7CT-05...

Related Keywords

Poland ,Guillaume Van Renterghem ,Bartosz Sawulski ,Michal Walczak ,Twitter ,International Investorrelations ,Linkedin ,Targeted Protein Degradation ,Chief Scientific Officer ,Hepatocellular Carcinoma ,Captor Therapeutics ,View Bartosz ,Warsaw Stock Exchange Ctx ,